Bank of America Has Lowered Expectations for Myriad Genetics (NASDAQ:MYGN) Stock Price
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective decreased by Bank of America from $13.00 to $11.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an “underperform” rating on the stock. Bank of America‘s price target points to a potential upside of 5.57% from […]
Myriad Genetics (NASDAQ:MYGN – Get Free Report) had its price objective decreased by Bank of America from $13.00 to $11.00 in a research report issued to clients and investors on Monday,Benzinga reports. The brokerage currently has an “underperform” rating on the stock. Bank of America‘s price target points to a potential upside of 5.57% from […]
